RUNX2 and colorectal cancer: Liquiritigenin exerted significant inhibitory effects on the invasiveness and epithelial-mesenchymal transition of colorectal cancer cells by downregulating runt-related transcription factor 2 (Runx2) and inactivating the PI3K/AKT signaling pathway [117].